RELATED CONTENT
Technology
July 23, 2012 — The U.S. Food and Drug Administration (FDA) granted Ferring Pharmaceuticals Inc. approval to market Prepopik (sodium picosulfate, magnesium oxide and anhydrous citric acid) for oral solution indicated for cleansing of the colon as a preparation for colonoscopy in adults. Prepopik is a low-volume, orange-flavored, dual acting, stimulant and osmotic laxative.
July 23, 2012 